X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs PLETHICO PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD PLETHICO PHARMA MERCK LTD/
PLETHICO PHARMA
 
P/E (TTM) x 25.3 -1.1 - View Chart
P/BV x 2.8 0.0 16,876.6% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 MERCK LTD   PLETHICO PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
PLETHICO PHARMA
Mar-14
MERCK LTD/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,060395 268.4%   
Low Rs62331 1,990.4%   
Sales per share (Unadj.) Rs632.4604.4 104.6%  
Earnings per share (Unadj.) Rs45.732.5 140.8%  
Cash flow per share (Unadj.) Rs62.351.3 121.4%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.8473.6 82.1%  
Shares outstanding (eoy) m16.6034.08 48.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.4 377.4%   
Avg P/E ratio x18.46.6 280.5%  
P/CF ratio (eoy) x13.54.2 325.3%  
Price / Book Value ratio x2.20.5 480.9%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,9697,262 192.3%   
No. of employees `0001.6NA-   
Total wages/salary Rs m1,4871,596 93.2%   
Avg. sales/employee Rs Th6,631.9NM-  
Avg. wages/employee Rs Th939.2NM-  
Avg. net profit/employee Rs Th479.4NM-  
INCOME DATA
Net Sales Rs m10,49820,598 51.0%  
Other income Rs m242386 62.7%   
Total revenues Rs m10,74120,984 51.2%   
Gross profit Rs m1,1352,818 40.3%  
Depreciation Rs m276642 42.9%   
Interest Rs m01,593 0.0%   
Profit before tax Rs m1,102969 113.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343-138 -248.1%   
Profit after tax Rs m7591,107 68.6%  
Gross profit margin %10.813.7 79.1%  
Effective tax rate %31.1-14.3 -218.0%   
Net profit margin %7.25.4 134.5%  
BALANCE SHEET DATA
Current assets Rs m6,41018,877 34.0%   
Current liabilities Rs m8,82811,896 74.2%   
Net working cap to sales %-23.033.9 -68.0%  
Current ratio x0.71.6 45.8%  
Inventory Days Days5836 160.5%  
Debtors Days Days38198 19.4%  
Net fixed assets Rs m1,4069,861 14.3%   
Share capital Rs m166341 48.7%   
"Free" reserves Rs m6,28612,331 51.0%   
Net worth Rs m6,45516,139 40.0%   
Long term debt Rs m04,706 0.0%   
Total assets Rs m8,82833,146 26.6%  
Interest coverage xNM1.6-  
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.20.6 191.4%   
Return on assets %8.68.1 105.5%  
Return on equity %11.86.9 171.4%  
Return on capital %17.112.3 138.9%  
Exports to sales %8.321.4 38.7%   
Imports to sales %21.015.2 138.2%   
Exports (fob) Rs m8694,402 19.7%   
Imports (cif) Rs m2,2093,136 70.4%   
Fx inflow Rs m9594,402 21.8%   
Fx outflow Rs m2,6123,184 82.0%   
Net fx Rs m-1,6531,219 -135.7%   
CASH FLOW
From Operations Rs m1,0702,437 43.9%  
From Investments Rs m-750-6,265 12.0%  
From Financial Activity Rs m-1502,490 -6.0%  
Net Cashflow Rs m171-1,337 -12.8%  

Share Holding

Indian Promoters % 0.0 82.7 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 4.3 423.3%  
FIIs % 1.0 5.5 18.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 7.5 388.0%  
Shareholders   28,591 10,665 268.1%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   TTK HEALTHCARE  ALEMBIC LTD  CIPLA  ELDER PHARMA  SUVEN LIFE  

Compare MERCK LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 16, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - VENUS REMEDIES COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS